186 related articles for article (PubMed ID: 9046061)
1. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen.
Hanisch FG; Baldus SE
Histol Histopathol; 1997 Jan; 12(1):263-81. PubMed ID: 9046061
[TBL] [Abstract][Full Text] [Related]
2. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin.
Campbell BJ; Finnie IA; Hounsell EF; Rhodes JM
J Clin Invest; 1995 Feb; 95(2):571-6. PubMed ID: 7860740
[TBL] [Abstract][Full Text] [Related]
3. Expression of the pantumour Thomsen-Friedenreich antigen in the human placenta with the diagnosis of hydatidiform mole.
Richter DU; Jeschke U; Makovitzky J; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):2001-3. PubMed ID: 17649812
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Thomsen-Friedenreich (TF) antigen in the human placenta.
Richter DU; Jeschke U; Makovitzky J; Goletz S; Karsten U; Briese V; Friese K
Anticancer Res; 2000; 20(6D):5129-33. PubMed ID: 11326683
[TBL] [Abstract][Full Text] [Related]
5. Comparison of T-antigen expression in normal, premalignant, and malignant human colonic tissue using lectin and antibody immunohistochemistry.
Yuan M; Itzkowitz SH; Boland CR; Kim YD; Tomita JT; Palekar A; Bennington JL; Trump BF; Kim YS
Cancer Res; 1986 Sep; 46(9):4841-7. PubMed ID: 3731131
[TBL] [Abstract][Full Text] [Related]
6. Expression of the carbohydrate tumour marker SLeX, SLeA (CA19-9), LeY and Thomsen-Friedenreich (TF) antigen on normal squamous epithelial tissue of the penis and vagina.
Wiest I; Schulze S; Kuhn C; Seliger C; Hausmann R; Betz P; Mayr D; Friese K; Jeschke U
Anticancer Res; 2007; 27(4A):1981-8. PubMed ID: 17649809
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro.
Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U
Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919
[TBL] [Abstract][Full Text] [Related]
8. Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries.
Peletskaya EN; Glinsky VV; Glinsky GV; Deutscher SL; Quinn TP
J Mol Biol; 1997 Jul; 270(3):374-84. PubMed ID: 9237904
[TBL] [Abstract][Full Text] [Related]
9. Mucin 1, Thomsen-Friedenreich expression and galectin-1 binding in endometrioid adenocarcinoma: an immunohistochemical analysis.
Mylonas I; Mayr D; Walzel H; Shabani N; Dian D; Kuhn C; Kunze S; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):1975-80. PubMed ID: 17649808
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Thomsen-Friedenreich (TF) tumor antigen in human abort placentas.
Richter DU; Jeschke U; Bergemann C; Makovitzky J; Lüthen F; Karsten U; Briese V
Anticancer Res; 2005; 25(3A):1675-8. PubMed ID: 16033081
[TBL] [Abstract][Full Text] [Related]
11. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
12. Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection.
Kumar SR; Sauter ER; Quinn TP; Deutscher SL
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6868-71. PubMed ID: 16203776
[TBL] [Abstract][Full Text] [Related]
13. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
Schindlbeck C; Jeschke U; Schulze S; Karsten U; Janni W; Rack B; Krajewski S; Sommer H; Friese K
Breast Cancer Res Treat; 2007 Jan; 101(1):17-25. PubMed ID: 16807671
[TBL] [Abstract][Full Text] [Related]
15. A new monoclonal antibody (A78-G/A7) to the Thomsen-Friedenreich pan-tumor antigen.
Karsten U; Butschak G; Cao Y; Goletz S; Hanisch FG
Hybridoma; 1995 Feb; 14(1):37-44. PubMed ID: 7539400
[TBL] [Abstract][Full Text] [Related]
16. The Thomsen-Friedenreich antigen on human urothelial cell lines detectable by peanut lectin and monoclonal antibody raised against human glycophorin A.
Radzikowski CZ; Steuden I; Wiedlocha A; Kieler J; Tromholt V
Anticancer Res; 1989; 9(1):103-7. PubMed ID: 2650614
[TBL] [Abstract][Full Text] [Related]
17. Thomsen-Friedenreich glycotope is expressed in developing and normal kidney but not in renal neoplasms.
Toma V; Zuber C; Sata T; Komminoth P; Hailemariam S; Eble JN; Heitz PU; Roth J
Hum Pathol; 2000 Jun; 31(6):647-55. PubMed ID: 10872656
[TBL] [Abstract][Full Text] [Related]
18. Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas.
Jeschke U; Mayr D; Schiessl B; Mylonas I; Schulze S; Kuhn C; Friese K; Walzel H
Placenta; 2007; 28(11-12):1165-73. PubMed ID: 17664004
[TBL] [Abstract][Full Text] [Related]
19. Immunodiagnostic potential of mucin (MUC2) and Thomsen-Friedenreich (TF) antigens in Egyptian patients with colorectal cancer.
El-Sayed IH; Lotfy M; Moawad M
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):91-7. PubMed ID: 21381504
[TBL] [Abstract][Full Text] [Related]
20. Multivalent scFv display of phagemid repertoires for the selection of carbohydrate-specific antibodies and its application to the Thomsen-Friedenreich antigen.
Ravn P; Danielczyk A; Jensen KB; Kristensen P; Christensen PA; Larsen M; Karsten U; Goletz S
J Mol Biol; 2004 Oct; 343(4):985-96. PubMed ID: 15476815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
